Company / Share Buybacks
Viking Therapeutics, Inc. Share Buybacks History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$6.8M
FY2023
5-year range
$6.8M / $6.8M
FY2019-FY2023
Trend
+0.0%
vs FY2022
Sector context
#39 of 48
Health Care
What the data says
Viking Therapeutics, Inc.'s share buybacks of $7M is lower than 81% of companies in the Health Care sector (FY2023). Improved from $38 to $7M over the past 7 years.
Based on SEC 10-K filings.
$7M in FY2023.
Improved from $38 to $7M over the past 7 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 48This company $6.8M Sector average $611.9M
▼
-98.9% below sector average
Key checks
Key Insights
- In FY2023, share buybacks increased 0.0% year-over-year.
- Ranks #39 out of 48 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $6.8M | +0.0% |
| FY2022 | $6.8M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $38 | +1800.0% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026